Phenomix Sciences and Mayo Clinic to Present Landmark Research at DDW 2025, Advancing Precision Obesity Medicine
Dexcom Launches First Nationwide Search for College Athletes With Diabetes to Join Season Four of Dexcom U
Express News | Shares of Diabetes Stocks Are Trading Lower Following Successful Obesity Data From Lilly
DexCom (NASDAQ:DXCM) Is Experiencing Growth In Returns On Capital
Express News | Diabetes Device Maker Dexcom Shares Down 3.1% Premarket After Lilly's Pill Leads to Weight Loss in Late-Stage Trial
DexCom (NasdaqGS:DXCM) Gains FDA Clearance For Dexcom G7 System
Express News | Johnson Fistel Has Commenced an Investigation on Behalf of Dexcom, Inc. Shareholders
RBC Capital Maintains DexCom(DXCM.US) With Buy Rating, Cuts Target Price to $100
Wells Fargo Sticks to Its Buy Rating for Dexcom (DXCM)
BTIG Maintains DexCom(DXCM.US) With Buy Rating, Cuts Target Price to $107
BTIG Remains a Buy on Dexcom (DXCM)
Notable Healthcare Headlines of the Week: Norvatis, Novo Nordisk, Eli Lilly in Focus
Barclays Maintains DexCom(DXCM.US) With Hold Rating, Maintains Target Price $90
Citi Maintains DexCom(DXCM.US) With Buy Rating
Bernstein Maintains DexCom(DXCM.US) With Buy Rating, Maintains Target Price $100
DexCom Shares May Rise as G7 15-Day CGM System Gets FDA Clearance
What Does the Market Think About DexCom?
Dexcom (DXCM) Receives a Buy From Citi
Dexcom's G7 Sensor Approval and Strategic Moves Drive Buy Rating
Barclays Keeps Their Hold Rating on Dexcom (DXCM)